SlideShare a Scribd company logo
1 of 34
Infectious disease epidemiology Influenza
Influenza Clinical Features Abrupt onset of fever and respiratory symptoms, including cough, rhinorrhea and sore throat Myalgia and headache are more common w/ influenza than with other respiratory infections Malaise Prostration  GI symptoms not common in adults, but 50% of infant and child infections may have vomiting, abdominal pain and diarrhea Usually lasts 3 to 5 days, but complications can prolong the illness in the elderly and people with chronic illnesses
Influenza Clinical Features – Complications: Some patients can develop primary influenza viral pneumonia, which can be fatal (uncommon) Secondary bacterial pneumonia may occur up to two weeks after the acute viral infection In infants and children, otitis media and croup are common complications Myocarditis, myositis and encephalitis are less frequent complications
Influenza Transmission
Influenza Transmission Spread through respiratory secretions of infected individuals (may contain up to 105 virus particles/mL) Infectious aerosols are generated during coughing, sneezing and talking Infectious secretions are also spread by direct (e.g. kissing) or indirect (e.g. nose-finger-doorknob) contact with respiratory mucosa
Influenza Transmission The inhaled virus attaches to columnar epithelial cells of the upper respiratory tract and initiates a new infection Incubation period is from 1 to 4 days Infected hosts are capable of transmitting the virus from shortly before the onset of clinical disease up to the 4th or 5th day of illness
Influenza Diagnosis Cannot be diagnosed from clinical signs or symptoms Only viral culture or serology can definitely identify the presence of influenza virus
Influenza The virus
Influenza The Virus A, B, and C types Type A Hemagglutinin (HA) and neuraminidase (NA) are surface glycoproteins that are important in both pathogenesis and immune protection from infection: subtypes of influenza A virus are determined by these two surface antigens
Influenza Type A virus HA functions as the attachment protein to gylcoproteins on columnar epithelial cells of the respiratory tract Specific antibodies to HA epitopes prevent attachment and entry of the influenza virus into the host cells HA specificity for receptor binding is a determinant of which species can be infected (host range) HA is a virulence determinant NA cleaves sialic acid residues to allow virus release from the host epithelial cell Specific anti-NA antibody presumably diminishes release of virions from host cells
Influenza Mechanisms of Antigenic Variation (most relevant to A type virus) A little background: RNA viruses are low-fidelity, i.e. high rate of spontaneous mutation Influenza A is segmented, which contributes even more to it’s low-fidelity
Influenza Mechanisms of Antigenic Variation Antigenic drift: The minor yet frequent genetic changes in the HA and NA surface antigens  There is roughly a 1% change in the amino acid composition of the HA antigen per year
Influenza Mechanisms of Antigenic Variation Antigenic shift: Major changes in the HA or NA surface antigens, or both, lead to a new subtype It is believed that after several decades (typically between 10 and 30 years) of circulation of a specific A subtype, most members of the population will have antibody to that subtype This produces selective pressure on the virus and leads to new shift variants
Influenza Epidemiology – Annual Epidemics Follow predictable pattern In North America, usually occur between November and March: manifested first by high rates of school and industrial absenteeism, followed by an increase in visits to health care facilities, an increase in pneumonia and influenza hospital admissions, and finally an increase in deaths from pneumonia or influenza In any specific locality epidemic influenza often begins abruptly, reaches a peak within three weeks, and usually ends by 8 weeks A city or region can experience two sequential or overlapping epidemics with different strains of viruses in a single winter
Influenza Epidemiology – Annual Epidemics In the southern hemisphere, epidemics usually occur in the May to Sept. winter season; northern, Oct. to May In tropics, local/regional disease seasonality can follow the monsoons (or year-round isolation of virus may be observed) Winter season viral spread is thought to be favored by the fact that the virus survives better in environments of lower temperature and humidity In tropical areas, however, viral spread during the monsoon season suggests that indoor crowding caused by the weather may be a more important factor in such regions
Influenza Epidemiology – Annual Epidemics In general, rates of infection are higher in infants and children than adults, and rates of hospitalization are highest in infants and lower in children and high in the elderly  Families with children have the highest rates of infection Therefore, relatively immunologically naïve children are important in the spread of epidemic strains
Influenza Epidemiology – Annual Epidemics Each epidemic varies in size and impact, determined by the degree of antigenic variation of the new virus, its virulence, and the level of existing protective immunity in the infected population During average epidemics in North America, attack rates are generally between 10% and 20% in large populations, however certain subpopulations (school children, nursing home residents) and local outbreaks can have attack rates of 40% to 50%.
Influenza Epidemiology – Annual Epidemics Incidence is very difficult to measure because most people infected do not present to a hospital or clinician, and not all people with influenza-like illness have the flu Nevertheless, CDC estimates between 35 and 50 million cases each year in the United States Accurate global estimates would be near impossible to produce
Influenza Epidemiology – Annual Epidemics Over 20,000 influenza-associated excess deaths occurred in the US during each of nine epidemics between 1972 and 1991, and more than 40,000 deaths occurred during three of them Annual winter increase in all mortality is substantially due to influenza People aged 65 years or older account for 90% of the excess deaths associated with annual epidemics Since the 1990s, influenza has been associated with an average of 226,000 hospitalizations per year in the US
Influenza Epidemiology– Pandemics These are shift events Five in the last 100 years: 1918 H1N1 – the most catastrophic, with a 20% case-fatality and killing between 50 and 100 million people worldwide 1957 H1N1 to H2N2 1968 H2N2 to H3N2 1977 H1N1 reappeared causing 50% attack rates in people born after 1956 Until 2009 the old H1N1 and H3N2 subtypes co-circulated the world together 2009 new H1N1 replaces previous subtypes
Influenza Epidemiology– Surveillance Sentinel physician surveillance network: apprx 1000 physicians across the US record the total # of patients seen and the total with influenza-like illness from Oct-May Collaborating lab surveillance system: 75 WHO labs and 50 US labs record the total # of specimens received respiratory virus testing, and the total # positive influenza isolates The 122-city mortality reporting system: % of deaths listed with pneumonia or influenza
Influenza Epidemiology – Surveillance State and territorial epidemiologists’ report of  influenza activity levels Influenza pediatric mortality: respiratory deaths in children under 18 is now reportable 10 states require reporting of hospital admissions related to influenza in children “True” incidence data is reported by MMWR: comes from influenza hospitalization among children at the county level in three states
Influenza Epizootic Infections and Evolutionary History Birds – water fowl Pigs – epithelial receptors for both avian and human HA antigen Humans – unstable subtypes
Influenza Prevention and Treatment 4 tried and true methods
Influenza Vaccines Old targets groups Persons at increased risk for complications Persons aged 50-64 years Persons who can transmit influenza to those at high risk Healthcare workers Pregnant women Persons infected with HIV Breastfeeding mothers Travelers General population New targets groups (CDC 2010): everyone >6 months old
Influenza Vaccines - Strategy Virus mutability and antigenic drift require that a new vaccine is produced each year to counter the new antigenic variants that arise Vaccination of healthy adults should reduce reported respiratory illness by 20% and absenteeism by 36% Vaccination of healthy children should reduce all otitis media episodes by 40% and immunization of day-care children reduces illness in their families Inactivated versus live attenuated vaccines
Influenza Anti-viral drugs (eg. Oseltamivir) Can limit disease in persons infected Can limit the spread of infection among those who are infectious
Influenza Stay home and rest when sick
Influenza Hand washing

More Related Content

What's hot (20)

Influenza(Virology)
Influenza(Virology)Influenza(Virology)
Influenza(Virology)
 
EPIDEMIOLOGY OF INFLUENZA
EPIDEMIOLOGY OF INFLUENZAEPIDEMIOLOGY OF INFLUENZA
EPIDEMIOLOGY OF INFLUENZA
 
Influenza
InfluenzaInfluenza
Influenza
 
Nipah Virus infection
Nipah Virus infectionNipah Virus infection
Nipah Virus infection
 
Influenza virus-Flu
Influenza virus-FluInfluenza virus-Flu
Influenza virus-Flu
 
Influenza
InfluenzaInfluenza
Influenza
 
Influenza Virus
Influenza VirusInfluenza Virus
Influenza Virus
 
Chicken pox
Chicken poxChicken pox
Chicken pox
 
Smallpox
Smallpox Smallpox
Smallpox
 
Rabies
Rabies Rabies
Rabies
 
Corona virus
Corona virusCorona virus
Corona virus
 
Nipah virus
Nipah virusNipah virus
Nipah virus
 
Influenza a b
Influenza a bInfluenza a b
Influenza a b
 
Influenza infection
Influenza infectionInfluenza infection
Influenza infection
 
Swine flu
Swine fluSwine flu
Swine flu
 
Arboviruses
ArbovirusesArboviruses
Arboviruses
 
Arboviruses
ArbovirusesArboviruses
Arboviruses
 
Zika virus disease
Zika virus diseaseZika virus disease
Zika virus disease
 
Lecture 7. influenza
Lecture 7. influenzaLecture 7. influenza
Lecture 7. influenza
 
Nipah: An Introduction
Nipah: An IntroductionNipah: An Introduction
Nipah: An Introduction
 

Viewers also liked

Music Networks Presentation
Music Networks PresentationMusic Networks Presentation
Music Networks Presentationericnholmes
 
約旦華語老師數位教學訓練
約旦華語老師數位教學訓練約旦華語老師數位教學訓練
約旦華語老師數位教學訓練韶君 徐
 
Belajar daripada kehidupan
Belajar daripada kehidupanBelajar daripada kehidupan
Belajar daripada kehidupanAhmad Rashid
 

Viewers also liked (20)

1 Christine Buhl Andersen, Formandens Tale
1 Christine Buhl Andersen, Formandens Tale1 Christine Buhl Andersen, Formandens Tale
1 Christine Buhl Andersen, Formandens Tale
 
Forskningen i samlingerne
Forskningen i samlingerneForskningen i samlingerne
Forskningen i samlingerne
 
83 michael h+©jlundrasmussen_aben
83 michael h+©jlundrasmussen_aben83 michael h+©jlundrasmussen_aben
83 michael h+©jlundrasmussen_aben
 
Sarah Giersing: Skriften på væggen. ODM Internationalt Formidlingsseminar 2011
Sarah Giersing: Skriften på væggen. ODM Internationalt Formidlingsseminar 2011Sarah Giersing: Skriften på væggen. ODM Internationalt Formidlingsseminar 2011
Sarah Giersing: Skriften på væggen. ODM Internationalt Formidlingsseminar 2011
 
Ken Arnold, Welcome Collection
Ken Arnold, Welcome Collection Ken Arnold, Welcome Collection
Ken Arnold, Welcome Collection
 
57 Mie Buus, Udkantspuljen
57 Mie Buus, Udkantspuljen57 Mie Buus, Udkantspuljen
57 Mie Buus, Udkantspuljen
 
22 Charlotta Lindblom, Smededammen
22 Charlotta Lindblom, Smededammen22 Charlotta Lindblom, Smededammen
22 Charlotta Lindblom, Smededammen
 
Snow
SnowSnow
Snow
 
82 Michael Højlund, Cat kons vest
82 Michael Højlund, Cat kons vest82 Michael Højlund, Cat kons vest
82 Michael Højlund, Cat kons vest
 
palladium
palladiumpalladium
palladium
 
Marianne Høyem Andreasen
Marianne Høyem AndreasenMarianne Høyem Andreasen
Marianne Høyem Andreasen
 
Music Networks Presentation
Music Networks PresentationMusic Networks Presentation
Music Networks Presentation
 
Katrine Kølle Hansen
Katrine Kølle HansenKatrine Kølle Hansen
Katrine Kølle Hansen
 
約旦華語老師數位教學訓練
約旦華語老師數位教學訓練約旦華語老師數位教學訓練
約旦華語老師數位教學訓練
 
Trabajo de diseño 2 eso graphic design
Trabajo de diseño 2 eso graphic designTrabajo de diseño 2 eso graphic design
Trabajo de diseño 2 eso graphic design
 
Kirsten Nelleman Nielsen, De levede og de døde i hårup - landsbyen
Kirsten Nelleman Nielsen, De levede og de døde i hårup - landsbyenKirsten Nelleman Nielsen, De levede og de døde i hårup - landsbyen
Kirsten Nelleman Nielsen, De levede og de døde i hårup - landsbyen
 
Belajar daripada kehidupan
Belajar daripada kehidupanBelajar daripada kehidupan
Belajar daripada kehidupan
 
Paul Burtenshaw Breaking the barrier
Paul Burtenshaw Breaking the barrierPaul Burtenshaw Breaking the barrier
Paul Burtenshaw Breaking the barrier
 
71 Per Hadsund, Tørring af ark jern
71 Per Hadsund, Tørring af ark jern71 Per Hadsund, Tørring af ark jern
71 Per Hadsund, Tørring af ark jern
 
2 Lars Just, Strategisk panel, odm, 131114
2 Lars Just, Strategisk panel, odm, 1311142 Lars Just, Strategisk panel, odm, 131114
2 Lars Just, Strategisk panel, odm, 131114
 

Similar to Influenza

2009 H1N1: Overview of a Pandemic
2009 H1N1: Overview of a Pandemic2009 H1N1: Overview of a Pandemic
2009 H1N1: Overview of a PandemicChrissyCarlson
 
Influenz1.docx
Influenz1.docxInfluenz1.docx
Influenz1.docxKoh Fenqi
 
Influenza lecture for the medical students
Influenza lecture for the medical studentsInfluenza lecture for the medical students
Influenza lecture for the medical studentsAditiJain307041
 
viralpneumonia influenza.pptx
viralpneumonia influenza.pptxviralpneumonia influenza.pptx
viralpneumonia influenza.pptxAshraf Shaik
 
Trivalent Inacivated Seasonal Influenza Vaccine 2017-2018
Trivalent Inacivated Seasonal Influenza Vaccine  2017-2018  Trivalent Inacivated Seasonal Influenza Vaccine  2017-2018
Trivalent Inacivated Seasonal Influenza Vaccine 2017-2018 Ashraf ElAdawy
 
Upper Respiratory Tract Infection 1.pptx
Upper Respiratory Tract Infection 1.pptxUpper Respiratory Tract Infection 1.pptx
Upper Respiratory Tract Infection 1.pptxFarqadAlBaidhani
 
Acute rheumatic fever - Dr. Akif Baig
Acute rheumatic fever - Dr. Akif BaigAcute rheumatic fever - Dr. Akif Baig
Acute rheumatic fever - Dr. Akif Baigakifab93
 
Lower respiratory tract infection
Lower respiratory tract infectionLower respiratory tract infection
Lower respiratory tract infectionSuzana Arbutina
 
Upper respiratory infections
Upper respiratory infectionsUpper respiratory infections
Upper respiratory infectionsChris Kokkola
 
Seasonal influenza - current perspective with special reference to India - au...
Seasonal influenza - current perspective with special reference to India - au...Seasonal influenza - current perspective with special reference to India - au...
Seasonal influenza - current perspective with special reference to India - au...Gaurav Gupta
 
Influenza and influenza vaccine
Influenza and influenza vaccineInfluenza and influenza vaccine
Influenza and influenza vaccineDUVASU
 
2009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N12009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N1egermann
 

Similar to Influenza (20)

2009 H1N1: Overview of a Pandemic
2009 H1N1: Overview of a Pandemic2009 H1N1: Overview of a Pandemic
2009 H1N1: Overview of a Pandemic
 
orthomyxoviridae
orthomyxoviridaeorthomyxoviridae
orthomyxoviridae
 
Influenz1.docx
Influenz1.docxInfluenz1.docx
Influenz1.docx
 
Viral pneumonia
Viral pneumoniaViral pneumonia
Viral pneumonia
 
Influenza (2)local file
Influenza (2)local fileInfluenza (2)local file
Influenza (2)local file
 
Rhinovirus
RhinovirusRhinovirus
Rhinovirus
 
Influenza lecture for the medical students
Influenza lecture for the medical studentsInfluenza lecture for the medical students
Influenza lecture for the medical students
 
viralpneumonia influenza.pptx
viralpneumonia influenza.pptxviralpneumonia influenza.pptx
viralpneumonia influenza.pptx
 
Influenza8p
Influenza8pInfluenza8p
Influenza8p
 
Pandemic101
Pandemic101Pandemic101
Pandemic101
 
Trivalent Inacivated Seasonal Influenza Vaccine 2017-2018
Trivalent Inacivated Seasonal Influenza Vaccine  2017-2018  Trivalent Inacivated Seasonal Influenza Vaccine  2017-2018
Trivalent Inacivated Seasonal Influenza Vaccine 2017-2018
 
H1 N1
H1 N1H1 N1
H1 N1
 
Upper Respiratory Tract Infection 1.pptx
Upper Respiratory Tract Infection 1.pptxUpper Respiratory Tract Infection 1.pptx
Upper Respiratory Tract Infection 1.pptx
 
Acute rheumatic fever - Dr. Akif Baig
Acute rheumatic fever - Dr. Akif BaigAcute rheumatic fever - Dr. Akif Baig
Acute rheumatic fever - Dr. Akif Baig
 
(Hiv) pediatrics
(Hiv) pediatrics(Hiv) pediatrics
(Hiv) pediatrics
 
Lower respiratory tract infection
Lower respiratory tract infectionLower respiratory tract infection
Lower respiratory tract infection
 
Upper respiratory infections
Upper respiratory infectionsUpper respiratory infections
Upper respiratory infections
 
Seasonal influenza - current perspective with special reference to India - au...
Seasonal influenza - current perspective with special reference to India - au...Seasonal influenza - current perspective with special reference to India - au...
Seasonal influenza - current perspective with special reference to India - au...
 
Influenza and influenza vaccine
Influenza and influenza vaccineInfluenza and influenza vaccine
Influenza and influenza vaccine
 
2009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N12009 Sept 1 Nwrc H1 N1
2009 Sept 1 Nwrc H1 N1
 

Influenza

  • 2. Influenza Clinical Features Abrupt onset of fever and respiratory symptoms, including cough, rhinorrhea and sore throat Myalgia and headache are more common w/ influenza than with other respiratory infections Malaise Prostration GI symptoms not common in adults, but 50% of infant and child infections may have vomiting, abdominal pain and diarrhea Usually lasts 3 to 5 days, but complications can prolong the illness in the elderly and people with chronic illnesses
  • 3. Influenza Clinical Features – Complications: Some patients can develop primary influenza viral pneumonia, which can be fatal (uncommon) Secondary bacterial pneumonia may occur up to two weeks after the acute viral infection In infants and children, otitis media and croup are common complications Myocarditis, myositis and encephalitis are less frequent complications
  • 5. Influenza Transmission Spread through respiratory secretions of infected individuals (may contain up to 105 virus particles/mL) Infectious aerosols are generated during coughing, sneezing and talking Infectious secretions are also spread by direct (e.g. kissing) or indirect (e.g. nose-finger-doorknob) contact with respiratory mucosa
  • 6.
  • 7.
  • 8. Influenza Transmission The inhaled virus attaches to columnar epithelial cells of the upper respiratory tract and initiates a new infection Incubation period is from 1 to 4 days Infected hosts are capable of transmitting the virus from shortly before the onset of clinical disease up to the 4th or 5th day of illness
  • 9.
  • 10. Influenza Diagnosis Cannot be diagnosed from clinical signs or symptoms Only viral culture or serology can definitely identify the presence of influenza virus
  • 12. Influenza The Virus A, B, and C types Type A Hemagglutinin (HA) and neuraminidase (NA) are surface glycoproteins that are important in both pathogenesis and immune protection from infection: subtypes of influenza A virus are determined by these two surface antigens
  • 13. Influenza Type A virus HA functions as the attachment protein to gylcoproteins on columnar epithelial cells of the respiratory tract Specific antibodies to HA epitopes prevent attachment and entry of the influenza virus into the host cells HA specificity for receptor binding is a determinant of which species can be infected (host range) HA is a virulence determinant NA cleaves sialic acid residues to allow virus release from the host epithelial cell Specific anti-NA antibody presumably diminishes release of virions from host cells
  • 14. Influenza Mechanisms of Antigenic Variation (most relevant to A type virus) A little background: RNA viruses are low-fidelity, i.e. high rate of spontaneous mutation Influenza A is segmented, which contributes even more to it’s low-fidelity
  • 15. Influenza Mechanisms of Antigenic Variation Antigenic drift: The minor yet frequent genetic changes in the HA and NA surface antigens There is roughly a 1% change in the amino acid composition of the HA antigen per year
  • 16. Influenza Mechanisms of Antigenic Variation Antigenic shift: Major changes in the HA or NA surface antigens, or both, lead to a new subtype It is believed that after several decades (typically between 10 and 30 years) of circulation of a specific A subtype, most members of the population will have antibody to that subtype This produces selective pressure on the virus and leads to new shift variants
  • 17. Influenza Epidemiology – Annual Epidemics Follow predictable pattern In North America, usually occur between November and March: manifested first by high rates of school and industrial absenteeism, followed by an increase in visits to health care facilities, an increase in pneumonia and influenza hospital admissions, and finally an increase in deaths from pneumonia or influenza In any specific locality epidemic influenza often begins abruptly, reaches a peak within three weeks, and usually ends by 8 weeks A city or region can experience two sequential or overlapping epidemics with different strains of viruses in a single winter
  • 18. Influenza Epidemiology – Annual Epidemics In the southern hemisphere, epidemics usually occur in the May to Sept. winter season; northern, Oct. to May In tropics, local/regional disease seasonality can follow the monsoons (or year-round isolation of virus may be observed) Winter season viral spread is thought to be favored by the fact that the virus survives better in environments of lower temperature and humidity In tropical areas, however, viral spread during the monsoon season suggests that indoor crowding caused by the weather may be a more important factor in such regions
  • 19.
  • 20.
  • 21. Influenza Epidemiology – Annual Epidemics In general, rates of infection are higher in infants and children than adults, and rates of hospitalization are highest in infants and lower in children and high in the elderly Families with children have the highest rates of infection Therefore, relatively immunologically naïve children are important in the spread of epidemic strains
  • 22. Influenza Epidemiology – Annual Epidemics Each epidemic varies in size and impact, determined by the degree of antigenic variation of the new virus, its virulence, and the level of existing protective immunity in the infected population During average epidemics in North America, attack rates are generally between 10% and 20% in large populations, however certain subpopulations (school children, nursing home residents) and local outbreaks can have attack rates of 40% to 50%.
  • 23. Influenza Epidemiology – Annual Epidemics Incidence is very difficult to measure because most people infected do not present to a hospital or clinician, and not all people with influenza-like illness have the flu Nevertheless, CDC estimates between 35 and 50 million cases each year in the United States Accurate global estimates would be near impossible to produce
  • 24. Influenza Epidemiology – Annual Epidemics Over 20,000 influenza-associated excess deaths occurred in the US during each of nine epidemics between 1972 and 1991, and more than 40,000 deaths occurred during three of them Annual winter increase in all mortality is substantially due to influenza People aged 65 years or older account for 90% of the excess deaths associated with annual epidemics Since the 1990s, influenza has been associated with an average of 226,000 hospitalizations per year in the US
  • 25. Influenza Epidemiology– Pandemics These are shift events Five in the last 100 years: 1918 H1N1 – the most catastrophic, with a 20% case-fatality and killing between 50 and 100 million people worldwide 1957 H1N1 to H2N2 1968 H2N2 to H3N2 1977 H1N1 reappeared causing 50% attack rates in people born after 1956 Until 2009 the old H1N1 and H3N2 subtypes co-circulated the world together 2009 new H1N1 replaces previous subtypes
  • 26. Influenza Epidemiology– Surveillance Sentinel physician surveillance network: apprx 1000 physicians across the US record the total # of patients seen and the total with influenza-like illness from Oct-May Collaborating lab surveillance system: 75 WHO labs and 50 US labs record the total # of specimens received respiratory virus testing, and the total # positive influenza isolates The 122-city mortality reporting system: % of deaths listed with pneumonia or influenza
  • 27. Influenza Epidemiology – Surveillance State and territorial epidemiologists’ report of influenza activity levels Influenza pediatric mortality: respiratory deaths in children under 18 is now reportable 10 states require reporting of hospital admissions related to influenza in children “True” incidence data is reported by MMWR: comes from influenza hospitalization among children at the county level in three states
  • 28. Influenza Epizootic Infections and Evolutionary History Birds – water fowl Pigs – epithelial receptors for both avian and human HA antigen Humans – unstable subtypes
  • 29. Influenza Prevention and Treatment 4 tried and true methods
  • 30. Influenza Vaccines Old targets groups Persons at increased risk for complications Persons aged 50-64 years Persons who can transmit influenza to those at high risk Healthcare workers Pregnant women Persons infected with HIV Breastfeeding mothers Travelers General population New targets groups (CDC 2010): everyone >6 months old
  • 31. Influenza Vaccines - Strategy Virus mutability and antigenic drift require that a new vaccine is produced each year to counter the new antigenic variants that arise Vaccination of healthy adults should reduce reported respiratory illness by 20% and absenteeism by 36% Vaccination of healthy children should reduce all otitis media episodes by 40% and immunization of day-care children reduces illness in their families Inactivated versus live attenuated vaccines
  • 32. Influenza Anti-viral drugs (eg. Oseltamivir) Can limit disease in persons infected Can limit the spread of infection among those who are infectious
  • 33. Influenza Stay home and rest when sick